Motley Fool65d agoneutral
A New $21 Million Position Signals Confidence in This Post-IPO Drug DeveloperThis biotechnology firm leverages machine learning to design novel protein therapeutics targeting unmet medical needs.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
542last 24h
2521last 7d
483● bullish (7d)
259● bearish (7d)
197publishers
Financial Times83d agoneutral
Klarna breaks even for first time since blockbuster New York IPOKlarna broke even for the first time since its $15bn New York listing last September, marking a potential turning point for the European fintech...